Myogenic regulatory factors (MRFs) (MRFs)

Muscle-specific transcription factors, primarily the Myogenic Regulatory Factors (MRFs), are a family of basic helix-loop-helix (bHLH) proteins that govern the development and repair of skeletal muscle [UniProt P15172; Hernández-Hernández et al., 2017]. This group includes MyoD (MyoD1), Myf5, Myogenin (Myog), and MRF4 (Myf6), which act sequentially to commit progenitor cells to the myogenic lineage and drive their differentiation into mature myofibers [UniProt P15173; Buckingham & Rigby, 2014]. They function by binding to E-box DNA sequences (CANNTG) in the promoters of muscle-specific genes, often in coordination with Mef2 and other co-factors [StatPearls NBK537115]. In clinical contexts, the loss or inhibition of these factors contributes to muscle wasting diseases such as sarcopenia, cachexia, and various muscular dystrophies [Buckingham & Rigby, 2014]. Conversely, the failure of these factors to initiate terminal differentiation is a hallmark of rhabdomyosarcoma, a pediatric soft tissue cancer [Hernández-Hernández et al., 2017]. While direct pharmacological activation of these transcription factors is not yet clinically established, they are major targets for gene therapy and regenerative medicine [Buckingham & Rigby, 2014]. Research also explores the use of epigenetic modulators, such as HDAC inhibitors, to enhance MRF activity and promote muscle regeneration [StatPearls NBK537115]. Overall, they serve as critical nodes in the regulatory network that maintains muscle mass and functional integrity [UniProt P15172].

Other names

Muscle-specific transcription factorsMyogenic bHLH transcription factorsMyogenic factorsMRF family

MRFs function as transcriptional activators by forming heterodimers with E-proteins and binding to E-box DNA motifs (CANNTG) in the regulatory regions of muscle-specific genes, thereby recruiting chromatin-modifying complexes and the basal transcription machinery [Hernández-Hernández et al., 2017; Buckingham & Rigby, 2014].